Fractyl Health, Inc. Common Stock

GUTSNASDAQ • USD
ThemeBiotech - Drug Development›Metabolic & Cardiometabolic
0.81 USD
↘ 0.04 (5.19%)AT CLOSE (11:59 AM EDT)
0.82
↗ 0.01 (1.11%)
POST MARKET (AS OF 06:28 PM EDT)
Post Market
AS OF 06:28 PM EDT
0.82
↗ 0.01 (1.11%)
🟢Market: OPEN

Shares of Fractyl Health, Inc. Common Stock (GUTS) are trading at $0.88. GUTS shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, GUTS trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Jul 17, 2026.

Open?$0.85
High?$0.85
Low?$0.80
Prev. Close?$0.85
Volume?1.4M
Avg. Volume?1.8M
VWAP?$0.83
Rel. Volume?0.78x
Bid / Ask
Bid?$0.71 × 100
Ask?$0.97 × 100
Spread?$0.26
Midpoint?$0.84
Valuation & Ratios
Market Cap?134.9M
Shares Out?158.6M
Float?74.4M
Float %?54.3%
P/E Ratio?N/A
P/B Ratio?6.31
EPS?-$0.68
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Fractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D). Its Revita and Rejuva candidates are designed to target root causes of metabolic diseases, allowing the company to advance metabolic disease treatment from chronic management towards prevention and reversion of the disease. The Revita DMR System (Revita), its lead product candidate, is based on its insights surrounding the potential role of the gut in obesity.
Themes
Biotech - Drug Development›Metabolic & CardiometabolicMedical Devices & HealthTech›Surgical & Robotic Systems
Employees
73
Market Cap
135.5M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
www.fractyl.com
Listed
2024-02-02
Address
3 VAN DE GRAAFF DRIVE
BURLINGTON, MA 01803
Phone: 781-902-8800
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
61
Piotroski F-Score?0/9Weak
Altman Z-Score?-9.14Distress
Confidence?47%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?3.11%Low
Short Interest?2.3M
Days to Cover?1.4
Free Float74.4M
Avg Daily Volume1.7M
Settlement Date2026-06-30
Financial Health
Current Ratio?4.28Strong
Quick Ratio?4.28Strong
Cash Ratio?4.10Strong
Debt/Equity?1.41Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
29
6.31FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.1CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-505.2%WEAK▾
ROA?
S&P
3
-108.7%WEAK▾
Cash Flow & Enterprise
FCF?$-87835000
Enterprise Value?$101.8M
Fundamentals ratios updated end of day
MarketsMoversWatchlist